title: Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b.
authors.affiliation: Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece. kostam@ath.forthnet.gr
authors.forename: Melanie
authors.initials: M
authors.lastname: Deutsch
authors.forename: Emanuel K
authors.initials: EK
authors.lastname: Manesis
authors.forename: Emilia
authors.initials: E
authors.lastname: Hadziyannis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Vassilopoulos
authors.forename: Athanasios J
authors.initials: AJ
authors.lastname: Archimandritis
mesh_terms: D051722:ADAM Proteins / Q000097:blood / Q000172:deficiency / Q000276:immunology; D000071120:ADAMTS13 Protein; D000998:Antiviral Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D011092:Polyethylene Glycols; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood / Q000139:chemically induced* / Q000276:immunology; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human; C417083:peginterferon alfa-2b